Brief: Molecure Files IND To US FDA For OATD-01

Molecure SA

22/06/2023 17:28

June 22 (Reuters) - Molecure SA  MOCP.WA :
    * FILES INVESTIGATIONAL NEW DRUG (IND) APPLICATION TO US FDA
FOR
PARTICLE OATD-01
    * OATD-01 COMPLETED FIRST PHASE OF CLINICAL STUDIES
    * FILING OF IND DOCUMENTATION IS A NECESSARY STEP FOR
COMMENCEMENT
OF SECOND PHASE OF CLINICAL STUDIES IN US
    * SAID STUDIES GOAL IS, AMONG OTHERS, TO ASSESS EFFECTIVITY
AND
SAFETY OF OATD-01
    * EXPECTS INCLUSION OF FIRST PATIENT TO OCCUR IN Q4, 2023
    * ALSO EXPECTS FOR CLINICAL STUDY TO LAST 19-25 MONTHS, WITH
90
PATIENTS PARTICIPATING

Source text for Eikon:  ID:nEM5WLJNsa 
Further company coverage:  MOCP.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))